SpringWorks Therapeutics
在场
高管
查看带有其 19 名主要高管的组织结构图
SpringWorks Therapeutics 搜索最多的简介
- Saqib Islam, Chief Executive Officer and Director
- Freda Lewis-Hall, Director
- Julie Hambleton, Director
高管在SpringWorks Therapeutics变化
- Martin Mackay已作为Director加入公司 (新闻发布的2024七月30号).
创建提醒
跟踪 SpringWorks Therapeutics 的高管变动
药店
SpringWorks Therapeutics 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。
Popular M&A news in 药店
- Cosette Pharmaceuticals has announced the acquisition of Mayne Pharma (公布2025二月25号).
- Bain Capital 已收购 Mitsubishi Tanabe Pharma (公布2025二月12号).
- Crown Laboratories 已收购 Revance Therapeutics (公布2025二月9号).
药店 行业的其他推荐联系人
消息
SpringWorks Therapeutics 的最新新闻稿
- SpringWorks Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights | SpringWorks Therapeutics
- SpringWorks Therapeutics to Present at the 2022 Wedbush PacGrow Healthcare Conference | SpringWorks Therapeutics
- SpringWorks Therapeutics Appoints Carlos Albán to its Board of Directors | SpringWorks Therapeutics
- SpringWorks Therapeutics to Present Progress Across the Company’s Targeted Oncology Portfolio at Virtual R&D Day | SpringWorks Therapeutics
- SpringWorks Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference | SpringWorks Therapeutics
- SpringWorks Therapeutics Highlights Nirogacestat Clinical Data at the 2022 ASCO Annual Meeting | SpringWorks Therapeutics
- SpringWorks Therapeutics Announces Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase 3 DeFi Trial in Adult Patients with Progressing Desmoid Tumors | SpringWorks Therapeutics
- SpringWorks Therapeutics to Host Virtual R&D Day on June 10, 2022 | SpringWorks Therapeutics
- SpringWorks Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares | SpringWorks Therapeutics
- SpringWorks Therapeutics Announces Pricing of Public Offering of Common Stock | SpringWorks Therapeutics
- View more press releases Close
